12:12pm PST - December 8th, 2021

As a patient I would have liked to see 2 more arms- D-Rvd-ASCT-D & D-RVd-ASCT-R 2 see what is the optimum maintenance therapy- monthly Dara would be much nicer than daily Revlimid IMHO. I guess it would take too many participants to power a trial of this nature #ASH21 #MMSM https://t.co/uVft0rrH8T

2 retweets   0 likes  - @MyelomaTeacher - Cindy Chmielewski (@MyelomaTeacher)